Sinsin Pharmaceutical Co., Ltd

₩3,780As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:002800Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (6.91%)
Div yield 2.12%
ROE 18.28%
Pharmaceutical Preparations
Beta (5Y) 0.23
PE TTM 4.259
TSR TTM (26.99%)
Mkt cap ₩57.34B
ROIC 11.58%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,376
15.75%
(47.61%)
Hold 12|10|8|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
97.41
104.23
104.64
111.31
22.63%
28.31%
16.03%
13.86%
Revenue₩B
2.828
2.932
3.012
2.973
3.29%
6.17%
9.16%
7.23%
Peers (US$42.28M)
Cap (US$)
PE
46.94M
—
43.06M
18.18x
Capital
TTM
5Y
10Y
Leveragex
2.147
0.107
0.097
EBIT/Intx
0.202
0.147
0.139
Own earn%
45.16
3.22
4.12
Sh yield%
38.30
27.98
27.66
Owners
Insiders/Inst%
12.22
75.34
Short interest%
5.88
SBC / revenue%
3.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
18–23
$1 testx
0.0
Incr. ROIC%
16